Literature DB >> 11353537

Surface-linked liposomal antigen induces ige-selective unresponsiveness regardless of the lipid components of liposomes.

Y Nakano1, M Mori, S Nishinohara, Y Takita, S Naito, H Kato, M Taneichi, K Komuro, T Uchida.   

Abstract

We have previously reported that antigen coupled with liposomes induced antigen-specific and IgE-selective unresponsiveness in mice. This antigen preparation was investigated for application in a novel vaccine protocol to induce minimal IgE synthesis. In this study, ovalbumin (OVA)-liposome conjugates were made using liposomes of four different lipid components, including unsaturated carrier lipid and three different saturated carrier lipids, after which the induction of anti-OVA antibody production was investigated in mice. All of the OVA-liposome conjugates induced IgE-selective unresponsiveness. The membrane fluidity of liposomes, as measured by detecting changes in the fluorescence polarization of a 1,6-diphenyl-1,3,5-hexatriene (DPH) probe located in the bilayers, was significantly higher in liposomes consisting of unsaturated carrier lipids than those of the other liposomes consisting of saturated carrier lipids. The highest titer of anti-OVA IgG was observed in mice immunized with OVA-liposomes made using liposomes consisting of unsaturated carrier lipids. In addition, among these OVA-liposomes, the one possessing the longest carbon chain induced the lowest IgG antibody production. These results suggest that the membrane fluidity of liposomes might affect the adjuvant effect of liposomes but not the induction of IgE-selective unresponsiveness in immunizations with surface-linked liposomal antigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353537     DOI: 10.1021/bc0001185

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  13 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes.

Authors:  Akira Takagi; Masanori Matsui; Satoshi Ohno; Hongying Duan; Osamu Moriya; Nobuharu Kobayashi; Hiroshi Oda; Masahito Mori; Akiharu Kobayashi; Maiko Taneichi; Tetsuya Uchida; Toshitaka Akatsuka
Journal:  Clin Vaccine Immunol       Date:  2009-08-12

3.  Liposome surface functionalization based on different anchoring lipids via Staudinger ligation.

Authors:  Pratima Vabbilisetty; Xue-Long Sun
Journal:  Org Biomol Chem       Date:  2014-02-28       Impact factor: 3.876

4.  Azide-reactive liposome for chemoselective and biocompatible liposomal surface functionalization and glyco-liposomal microarray fabrication.

Authors:  Yong Ma; Hailong Zhang; Valentinas Gruzdys; Xue-Long Sun
Journal:  Langmuir       Date:  2011-10-07       Impact factor: 3.882

Review 5.  Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.

Authors:  Forrest M Kievit; Miqin Zhang
Journal:  Adv Mater       Date:  2011-08-15       Impact factor: 30.849

Review 6.  Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists.

Authors:  Matthew Black; Amanda Trent; Matthew Tirrell; Colleen Olive
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

Review 7.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

8.  Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.

Authors:  Toru Ichihashi; Reiko Yoshida; Chihiro Sugimoto; Ayato Takada; Kiichi Kajino
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

Review 9.  Harnessing nanoparticles for immune modulation.

Authors:  Daniel R Getts; Lonnie D Shea; Stephen D Miller; Nicholas J C King
Journal:  Trends Immunol       Date:  2015-06-15       Impact factor: 16.687

10.  Emulsified phosphatidylserine, simple and effective peptide carrier for induction of potent epitope-specific T cell responses.

Authors:  Toru Ichihashi; Toshifumi Satoh; Chihiro Sugimoto; Kiichi Kajino
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.